CCDC138 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.094400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.123400E-01
Normal-vs-Stage2
6.521800E-01
Normal-vs-Stage3
4.013800E-01
Normal-vs-Stage4
4.526000E-01
Stage1-vs-Stage2
8.835200E-01
Stage1-vs-Stage3
5.800000E-01
Stage1-vs-Stage4
2.745600E-01
Stage2-vs-Stage3
5.338000E-01
Stage2-vs-Stage4
7.077900E-02
Stage3-vs-Stage4
8.569500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.725800E-01
Normal-vs-AfricanAmerican
6.979400E-01
Normal-vs-Asian
1.847770E-01
Caucasian-vs-AfricanAmerican
9.410400E-01
Caucasian-vs-Asian
1.904990E-01
AfricanAmerican-vs-Asian
3.325200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.065800E-01
Normal-vs-Female
6.379800E-01
Male-vs-Female
6.753200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.901400E-01
Normal-vs-Age(41-60Yrs)
8.040400E-01
Normal-vs-Age(61-80Yrs)
4.878800E-01
Normal-vs-Age(81-100Yrs)
9.934200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.644980E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.725640E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.371970E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.123600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.330600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.866850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.289200E-01
Normal-vs-Daily Drinker
6.256400E-01
Normal-vs-Weekly Drinker
9.488400E-01
Normal-vs-Occasional Drinker
9.632800E-01
Normal-vs-Social Drinker
7.949800E-01
Non Drinker-vs-Daily Drinker
4.083600E-01
Non Drinker-vs-Weekly Drinker
1.123590E-01
Non Drinker-vs-Occasional Drinker
1.995790E-01
Non Drinker-vs-Social Drinker
3.349000E-01
Daily Drinker-vs-Weekly Drinker
3.388600E-01
Daily Drinker-vs-Occasional Drinker
4.924200E-01
Daily Drinker-vs-Social Drinker
7.505800E-01
Weekly Drinker-vs-Occasional Drinker
8.522800E-01
Weekly Drinker-vs-Social Drinker
5.840400E-01
Occasional Drinker-vs-Social Drinker
7.431000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.706000E-01
Normal-vs-Grade 2
7.818800E-01
Normal-vs-Grade 3
8.103000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.228040E-02
Grade 1-vs-Grade 3
4.117800E-03
Grade 1-vs-Grade 4
6.706000E-01
Grade 2-vs-Grade 3
5.157200E-01
Grade 2-vs-Grade 4
7.818800E-01
Grade 3-vs-Grade 4
8.103000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.134600E-01
Normal-vs-NonDiabetic
5.677800E-01
Diabetic-vs-NonDiabetic
7.089600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.925800E-01
Normal-vs-NoPancreatitis
5.646200E-01
Pancreatitis-vs-NoPancreatitis
9.001600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.561800E-01
Normal-vs-N1
6.702600E-01
N0-vs-N1
5.700200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.936800E-01
Normal-vs-TP53-NonMutant
5.857000E-01
TP53-Mutant-vs-TP53-NonMutant
3.201200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
